$NVAX News

Novavax Stock Moves Higher Wednesday: What's Driving the Action?

Novavax, Inc. (NVAX) Q2 2026 Earnings Call Transcript

Novavax, Inc. 2026 Q2 - Results - Earnings Call Presentation

Novavax (NVAX) Reports Q2 Loss, Tops Revenue Estimates

Novavax (NASDAQ:NVAX) Exceeds Q2 CY2026 Expectations

Novavax Raises FY2026 Sales Guidance from $230.000M-$270.000M to $235.000M-$275.000M vs $389.234M Est

Novavax (NVAX) Stock Looks Stretched Even After a 97% Fall

NVAX Stock Rises Ahead Of Q2 Earnings As Focus Shifts To Licensing Deals

Novavax to Report Second Quarter 2026 Financial Results on August 6, 2026

Novavax: The Beaten-Down COVID-19 Darling

Novavax (NVAX) Stock Falls Amid Market Uptick: What Investors Need to Know

Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should Know

Novavax (NVAX) Registers a Bigger Fall Than the Market: Important Facts to Note

Novavax (NVAX) Leaves Russell Growth Indexes, Is The 32% Undervaluation Case Convincing?

Novavax (NVAX) Dropped From Major Russell Growth Indices And Why It Matters

Novavax (NVAX) Suffers a Larger Drop Than the General Market: Key Insights

Novavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on It

Novavax (NVAX) Stock Moves 1.36%: What You Should Know

Shah Capital Responds to Significant Shareholder Dissent at Novavax AGM

Investors Heavily Search Novavax, Inc. (NVAX): Here is What You Need to Know